Locations:
Search IconSearch

Provocative Testing & Coronary Artery Spasms

Provocative Ergonovine Testing Can Rule Out or Confirm the Diagnosis

Artery-690×380

When catheterization reveals normal coronary arteries in a patient complaining of angina, the tendency is to suspect a noncardiac condition. But if the patient continues to have angina, the diagnosis of coronary artery (CA) spasm should be considered.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

CA spasm producing angina in the absence of coronary artery disease (CAD) is a rare condition with certain characteristics that differentiate it from angina caused by ischemia. CA spasm angina predominantly occurs at rest, often awakening the patient at night or in the early morning. These episodes are transient, generally persisting for less than 15 minutes, and may cause syncope. Episodes can occur a few times yearly, a few times daily or infrequently.

The etiology of CA spasm is unknown. Most patients are aged 40 to 60. It is uncommon after age 70. Men and women are affected equally. In women, it may occur with menstruation. It is often associated with spasms in other arteries, causing conditions such as migraine or Reynaud’s syndrome.

Diagnostic dilemmas

Certain changes seen on EKG during an episode of spasm, most often ST elevation, can help make the diagnosis. The elevation generally resolves spontaneously in 10 to 15 minutes or in 1 to 2 minutes with nitroglycerin. Other patients may have ST-segment depression, ventricular tachycardia, ventricular fibrillation, complete heart block or asystole.

A Holter monitor makes it possible to capture some episodes of CA spasm. However, the quixotic nature of these spasms makes EKG documentation difficult to obtain.

Provocative testing

At Cleveland Clinic, we consider provocative ergonovine testing the definitive test for diagnosing this discreet syndrome. We have used it regularly 1972 and have found it to be effective in ruling out or confirming CA spasm. We consider the test safe: In our experience, no patient has died or developed a myocardial infarction during the test.

Advertisement

Ergonovine is a smooth muscle constrictor used primarily to stop postpartum bleeding. When given in the coronaries, ergonovine constricts the smooth muscle cells in the epithelium and triggers angina.

Provocative ergonomine testing is conducted in the cath lab. We first image the coronaries to ensure they are free of obstructive CAD. A bolus of ergonovine is then injected intravenously. Most patients will respond within 5 minutes. We take a complete EKG every minute, as changes in the EKG sometimes appear prior to angina. As soon as angina occurs, we reimage the coronaries. The patient is then given a syringe of premixed nitroglycerine or verapamil to reverse the spasm. The EKG should immediately normalize.

Less effective treatments

Numerous methods of testing for CA spasm have been tried over the years. Hyperventilation can trigger CA spasm, as can putting the patient’s hand in ice water for five minutes—an inhumane test that was popular in the 1970s. Neither was very sensitive, but occasionally worked.

Some institutions conduct provocative testing with acetocholine. However, this agent tends to elicit CA spasm in patients with CAD. We have seen patients who underwent provocative acetocholine testing and were diagnosed with CA spasm. When we repeated the test with ergonomine, the results were negative.

Stress testing is usually not helpful in making a diagnosis, unless the angina occurs with exertion. This scenario is the exception, rather than the rule.

Treating CA spasm

Once CA spasm is confirmed, calcium blockers can be used to control the spasms. A low dose is effective in some patients. Others require larger doses or even multiple calcium blockers.

Advertisement

Advertisement

Related Articles

illustration of two robot arms suturing a heart valve
Robotically Assisted Mitral Valve Repair: As Experience Deepens, Patient Applications Grow

Safety and efficacy are comparable to open repair across 2,600+ cases at Cleveland Clinic

illustrated human lungs with a podcast icon overlay
Optimizing Outcomes of Lung Transplant for Patients With Lung Failure (Podcast)

Insights on ex vivo lung perfusion, dual-organ transplant, cardiac comorbidities and more

illustration of a human heart with DNA double helix
Unmasking a Genetic Driver of Dilated Cardiomyopathy in People of African Ancestry

CD36 loss-of-function variant accounts for large portion of risk in this population

3D images of the aorta with downward-pointing arrows between them
Late Complications of Aortic Coarctation Repair Can Be Safely Treated

Series of 145 patients characterizes scope of presentations, interventions and outcomes

Ad